Module

Retreatment Strategies for Patients Failing First-Line Therapy

Source: Advanced Topics in Hepatitis C Management: Tools for Nurse Practitioners and Physician Assistants

Retreatment Strategies for Patients Failing First-Line Therapy


CME Program Director: Michael W. Fried, MD

Faculty:

HoChong Gilles, RN, MS, FNP
  • HoChong Gilles, RN, MS, FNP

CME CREDIT INFORMATION

Release Date: 06/28/07

Expiration Date: 06/27/08


Physicians: maximum of 1.5 AMA PRA Category 1 Credits

Registered Nurses: 1.5 Nursing CE credits

Physician Assistants: maximum of 1.5 hours of AAPA Category I (Preapproved) credits

Status: Please log in to view status


Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify causes of nonresponse and relapse to hepatitis C virus (HCV) therapy
  • Describe definitions of response during HCV therapy and key time points for monitoring response to treatment
  • Discuss diagnosis and management of common adverse effects of HCV therapy and strategies for monitoring patient adherence
  • Recall strategies for selecting optimal treatment for patients based on their baseline factors and previous course of therapy

Topics covered include:

  • Introduction
  • Treatment Response Patterns
  • Factors Contributing to Treatment Failure
  • Comorbidities as Predictors of Nonresponse
  • Other Factors Associated With Nonresponse
  • Assessing Factors Related to Nonresponse Before Retreatment
  • Retreatment Options in Nonresponders and Relapsers
  • Summary: Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

This program is supported by an independent educational grant provided by

Educational grants support only the CME-certified components of this program.